Literature DB >> 20360477

Proposal for a revised classification of systemic mastocytosis.

Animesh Pardanani, Ayalew Tefferi.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20360477     DOI: 10.1182/blood-2009-12-259085

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  4 in total

1.  The classification of systemic mastocytosis should include mast cell leukemia (MCL) and systemic mastocytosis with a clonal hematologic non-mast cell lineage disease (SM-AHNMD).

Authors:  Peter Valent; Michel Arock; Cem Akin; Wolfgang R Sperr; Andreas Reiter; Karl Sotlar; Karin Hartmann; Tracy I George; Knut Brockow; Hanneke C Kluin-Nelemans; Jason Gotlib; Dean D Metcalfe; Hans-Peter Horny
Journal:  Blood       Date:  2010-08-05       Impact factor: 22.113

2.  Isolated bone marrow mastocytosis: an underestimated subvariant of indolent systemic mastocytosis.

Authors:  Roberta Zanotti; Patrizia Bonadonna; Massimiliano Bonifacio; Anna Artuso; Donatella Schena; Maurizio Rossini; Omar Perbellini; Sabrina Colarossi; Marco Chilosi; Giovanni Pizzolo
Journal:  Haematologica       Date:  2010-12-29       Impact factor: 9.941

Review 3.  Update on diagnosis and treatment of mastocytosis.

Authors:  Knut Brockow; Johannes Ring
Journal:  Curr Allergy Asthma Rep       Date:  2011-08       Impact factor: 4.806

4.  Nilotinib in patients with systemic mastocytosis: analysis of the phase 2, open-label, single-arm nilotinib registration study.

Authors:  Andreas Hochhaus; Michele Baccarani; Francis J Giles; Philipp D le Coutre; Martin C Müller; Andreas Reiter; Helene Santanastasio; Mimi Leung; Steven Novick; Hagop M Kantarjian
Journal:  J Cancer Res Clin Oncol       Date:  2015-05-23       Impact factor: 4.553

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.